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Abstract: Tissue reactions to bacteria lead to proinflammatory reactions involving matrix metalloproteinases (MMPs). 
Synthetic protease inhibitors may offer new possibilities to regulate bacterial proteases. We investigated proteolytic activi-
ties of certain periodontal bacteria, their effects on the latent proMMP-9, and the effects of synthetic MMP inhibitors and 
a serine protease inhibitor Pefabloc. The strains studied were Porphyromonas gingivalis, Prevotella intermedia, Pepto-
streptoccus micros, Prevotella nigrescens, Fusobacterium nucleatum, and 5 Aggregatibacter actinomycetemcomitans se-
rotypes. Their gelatinolytic activities and the effects of certain synthetic MMP inhibitors and Pefabloc were analyzed by 
zymography. Bacterial effects on proMMP-9 conversion were investigated by Western immunoblot. All investigated 
periodontal bacteria produced gelatinolytic cell-bound and extracellular proteinases which could fragment latent 
proMMP-9, suggesting co-operative processing cascades in oral tissue remodeling. A. actinomycetemcomitans produced 
the weakest gelatinolytic activity. Synthetic proteinase inhibitors exhibited slight but clear reductive effects on the bacte-
rial proteolytic activities. We conclude that targeted anti-proteolytic treatment modalities against bacterial-host proteolytic 
cascades can be developed.  
Key Words: Oral micro-organisms, pro-matrix metalloproteinase-9, activation, proteolytic activity, synthetic proteinase inhibi-
tors.
INTRODUCTION 
  Tissue reaction to bacteria leads to an excessive host in-
flammatory response. Inflammatory cells secrete matrix-
degrading proteinases, including matrix metalloproteinases 
(MMPs). MMPs can degrade and modify almost all matrix 
and basement membrane proteins in growth and in normal 
tissue turnover [1-2]. Elevated MMP levels, especially neu-
trophil gelatinase B (MMP-9) together with lesser extent 
neutrophil collagenase-2 (MMP-8) are considered as poten-
tial markers for tissue destruction in inflammation [1-5]. The 
severity and course of tissue destruction in oral infections 
can be monitored by assessing oral fluid MMP-8 levels [6, 
7]. MMP-9 and -8 have also been shown to exert anti-infla- 
mmatory or
  In inflammation, gelatinase B (MMP-9
 defensive characteristics [8].  
) is often accom-
ddress correspondence to this author at the Institute of Dentistry, PB 41, 
panied by MMP-8 and granulocyte elastase [1-9, 10]. There 
is evidence that MMP-9 also increases during chronic in-
flammation [11]. Plasma MMP-9 seems to provide a useful 
marker of inflammation as it correlates with the leukocyte 
count and is not associated with the lipid profile [12]. Söder 
et al. [13] have shown that periodontal microorganisms can 
induce host response with increased release of MMP-9 and 
MMP-8 in the periodontal pockets. Simultaneously, higher 
MMP-9 concentrations were detected in blood samples of 
the patients indicating that this enzyme might either seep 
into the circulation from inflammatory cells in the periodon- 
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ple Preparation  
hogenic bacterial species 
tal pockets and/or that periodontal bacteria can trigger its up-
regulation also in blood. The MMPs are synthesized as inac-
tive proenzymes (proMMPs) and most are usually activated
extracellularly to be catalytically competent. The enzyme 
activity is controlled by endogenous and specific tissue 
inhibitors (TIMPs) [14].  
  Periodontal bacteria, such as Porphyromonas gingivalis, 
Prevotella intermedia, Peptostreptococcus micros, Prevotella 
nigrescens, Fusobacterium nucleatum, and Aggregatibacter 
actinomycetemcomitans, have been identified in sub-gingival 
plaque as putative pathogens [15]. These and other 
respective species can be useful in clinical decision making 
especially when diagnosing and treating patients with 
periodontal infections [16]. Our knowledge is still sparse 
regarding the actual pathogenic mechanisms and interactions 
between bacteria and host tissue in oral infections. We set 
this study out to investigate the proteolytic effect of certain 
bacteria with special emphasis on proMMP-9 and the effects 
of synthetic proteinase inhibitors.  
MATERIAL AND METHODS 
Bacterial Strains, Cultivation and Sam
  Six putative periodontal pat
were involved in this study. The used strains were P. 
ng gi ivalis  ATCC 33277, P. intermedia ATCC 25611, P. 
micros  ATCC 33270, P. nigrescens ATCC 33563, F. 
nucleatum ATCC 25586 and 5 serotypes (a, b, c, d, e) of A. 
actinomycetemcomitans ATCC 29523 (a), ATCC 43718 (b), 
ATCC 33384 (c), ATCC 787 (d), ATCC 37399 (e).  Proteolytic Activity of Oral Bacteria  The Open Dentistry Journal, 2008, Volume 2    97 
  The strains were grown in Brain Heart Infusion broth 
(BHI) (Difco Laboratories, Detroit, MI, USA) supplemented 
with hemin (1 mg/l) and menadione (0.5 mg/l) at 37°C to 
e
 that the final 
on
ity of P. gingivalis was high 
o
elatinolytic activity the sam-
ples of either supernatant or bacteria cells containing 5 µl of 
 were detected by modi-
fied [17] Western blotting kit according to protocol recom-
, Amersham, 
K
ine the inhibitory effects of different synthetic 
, Darmstadt, Germany), CMT3, 
e Mo-
S for Windows, version 13.0. P values 
nsidered statistically significant. 
utative periodontal pathogens studied showed 
proteolytic activity identified and measured by gelatin zy-
ingivalis yielded molecular weight bands at 
00 kDa. P. intermedia, 
ng bands around 130-
0
th ir early stationary phase, which was determined by 
measuring the growth curves spectrophotometrically. A. 
actinomycetemcomitans  serotypes were cultivated in 5 % 
CO2 atmosphere for 8 h and the other strains anaerobically 
(80 % N2, 10 % H2 and 10 % CO2) for 48 h. Purity of each 
strain was monitored by Gram stain. Both cell fractions and 
supernatant fractions were used in this study. 
  The cells were harvested by centrifugation at 14,000 rpm 
for 20 min at 4°C, washed 3 times with neutral phosphate 
buffer saline (PBS) and rediluted in PBS so
c centrations of the cells were twice higher of the original 
concentration for P. gingivalis and 4 times higher for the 
other species. The cell samples were sonicated on ice until 
cells were disrupted. The disruption of the cells was detected 
by phase-contrast microscope.  
  After centrifugation the supernatant fractions of the 
growth media were collected and lyophilized to get ten-fold 
higher concentrations. The activ
en ugh without concentration. 
Assay of Gelatinolytic Proteinase Activity of the Bacteria 
  For the measurements of g
P. gingivalis, 8 µl of P. intermedia, 15 µl of P. micros, P. 
nigrescens, F. nucleatum or different serotypes of A. actino-
mycetemcomitans were incubated in dark with 5 µl of 
Laemmli’s sample buffer without reductant for 2 h at RT for 
zymography. Low range prestained SDS-PAGE standards 
(Bio-Rad, Hercules, CA, USA) served as molecular weight 
markers. Zymography with 8 % sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) containing 
1 mg/ml gelatin fluorescent labelled with 2-methoxy-2, 4-
diphenyl-3-2H furanone (MDPF, Fluka, Buchs SG, Switzer-
land) as substrate was used. After electrophoresis, the gels 
were washed with Tris-HCl buffer, pH 7.5, containing 25 % 
Tween 80, 0.02 % NaN3, and then for 30 min with the same 
buffer supplemented with 0.5 mM CaCl2 and 1 µM ZnCl2. 
Finally the gels were incubated in 50 mM Tris-HCl buffer 
pH 7.5, containing 0.02 % NaN3, 0.5 mM CaCl2 and 1 µM 
ZnCl2 for overnight up to 7 days to detect gelatinolytic activ-
ity of proteinases. During incubation in the last buffer, dif-
ferent pH of 7.5, 6.5, 5.5, 4.5 and 4.0 were used to detect the 
optimum working condition of the bacterial gelatinolytic 
proteinases. The gels were monitored under UV-light within 
1 to 7 days, stained with Coomassie Brilliant Blue, scanned 
using GS-700 Imaging Densitometer and analyzed by Quan-
tity One –program (Bio-Rad). 
The Effects of Oral Bacteria on proMMP-9 
  The molecular forms of MMP-9
mended by the manufacturer (GE Healthcare
U ). Aliquots of 2.5 µl (20 ng/µl) of human recombinant 
proMMP-9 (Invitek GmbH, Berlin, Germany) were incu-
bated with culture media samples of P. gingivalis, P. inter-
media, P. micros, P. nigrescens, F. nucleatum, and different 
serotype of A. actinomycetemcomitans strains at 37°C for 
different periods of time (2 h, 4 h, 6 h, 8 h and 24 h). The 
samples of cell fractions were prosessed accordingly. The 
same sample volumes as in zymography assay were used. 
Because of the strong enzyme activity of P. gingivalis, 
shorter time of incubations (0 min, 20 min, 40 min and 60 
min) were also studied. For the positive control proMMP-9 
was co-incubated with aminophenylmercuric acetate (APMA, 
Sigma, St. Louis, MO, USA) for 2h at 37
oC. ProMMP-9 
without APMA was used as negative control. The incubated 
samples were boiled for 5 min with the same Laemmli’s 
sample buffer as in zymography assay. The gels were blotted 
onto nitrocellulose membrane according to instructions of 
the manufacturer. The primary antibody used was polyclonal 
anti-human MMP-9 (Calbiochem, Darmstadt, Germany) and 
the secondary antibody anti-rabbit IgG horseradish peroxi-
dase (1:800 dilution) (GE Healthcare). The proteins were 
visualized using ECL system and scanned by GS-700 Imag-
ing Densitometer for data analysis as described above for 
zymograms. 
Effect of Synthetic MMP Inhibitors and Pefabloc on the 
Bacterial Proteinases 
  To determ
MMP inhibitors on periodontal bacteria, 0.2 mM Ilomastat 
(ILM, Chemicon International, Inc., Temecula, CA, USA), 
EDTA (Merck KGaA
CMT308 (Collagenex Inc., Newtown, PA, USA), CTT1 (18)
 
and Pefabloc (PFB, a serine protease inhibitor, Boehringer 
Mannheim GmbH, Mannheim, Germany) were tested in this 
study. The CMTs have lost their antimicrobial activity but 
retained their ability to inhibit mammalian MMPs [17]. Each 
synthetic inhibitor were dissolved in dH2O and diluted with 
TNC-buffer to final concentration of 0.2 mM. The inhibitors 
were incubated together with the bacterial supernatants and 
cell bound fractions for 2 h at 37°C in dark. The same sam-
ple volumes as in zymography assay were used.  
  The gelatinolytic activity was measured as previously 
described with zymography method using MDPF-gelatin as 
substrate [18, 19]. The zymograms were analyzed by Bio-
Rad Model GS-700 Imaging Densitometer using th
lecular Analyst Program with correction of background val-
ues and results are expressed as arbitary units [18]. The re-
spective samples without inhibitors were used as controls.  
Statistical Analyses 
  The inhibition test was repeated 3 times and the inhibi-
tion results were compared to the control data using Stu-
dent’s t test with SPS
less than 0.05 were co
RESULTS 
Proteolytic Activity of the Bacteria 
  All the p
mography. P. g
the area of 70-100 kDa and beyond 2
P. micros, and P. nigrescens gave stro
17  kDa. In addition, P. intermedia yielded a band at 60 
kDa. The results were similar for both the cell supernatant or 
cell bound fractions. Fig. (1) represents proteolytic activity 
of cell supernatants. The cell bound fractions of F. nuclea-98    The Open Dentistry Journal, 2008, Volume 2  Bao et al. 
 
 
 
 
 
 
 
Fig. (1). Gelatinolytic activities in cell supernatants of the growth media of P. gingivalis (P.g.), P. intermedia (P.i.), P. micros (P.m.), P. 
nigrescens (P.n.), F. nucleatum (F.n.) and A. actinomycetemcomitans (A.a.) were studied with zymographic method. The gelatinolytic 
activities at 103-107 kDa produced by five serotypes of A.a (a, b, c, d, e) are indicated by arrow. 
tum and serotypes a and d of A. actinomycetemcomitans did 
not show any gelatinolytic activity whereas serotypes b, c, 
and e gave the same bands as the supernatant samples (data 
not shown). 
  The pH differences in incubation buffer did not have any 
effect on the proteinase activities of P. gingivalis, P. inter-
media, P. micros, P. nigrescens and A. actinomycetemcomi-
tans in pH range 7.5-5.5. However, when the pH dropped to 
4.5-4.0, the bands of P. intermedia, P. micros and P. nigres-
rowth media fragmented the 92 kDa proMMP-9 to 
s of MMP-9. 
 so strong that 
 pre-incubations with ILM, EDTA, CMT3, 
 and P. intermedia cell bound proteases as well as 
cens were markedly fainted (data not shown). 
The Effects of Oral Bacteria on proMMP-9 
  Western immunoblot analysis showed that supernatant of 
P. gingivalis, P. intermedia, P. micros, P. nigrescens, F. 
nucleatum (Fig. 2), and A. actinomycetemcomitans (data not 
shown) g
the 60 and 77-82 kDa lower molecular specie
The activity of P. gingivalis growth media was
it was possible to detect even after shorter incubation times 
(data not shown). After 6h incubation proMMP-9 was found 
to be completely degraded to undetectable small peptides 
(Fig. 2). 
Effects of the Synthetic MMP Inhibitors and a Synthetic 
Serine Proteinase Inhibitor Pefabloc on Bacterial Pro-
teinases 
 The  effects  of  P. gingivalis, P. intermedia, P. micros, P. 
nigrescens
CMT308, CTT1 and PFB on gelatin zymography are shown 
in Fig. (3A and B). Among all the inhibitors tested, ILM 
inhibited P. micros cell bound proteases, EDTA affected P. 
gingivalis
the P. nigrescens supernatant proteases, CMT3 inhibited P. 
intermedia cell bound proteases, CMT308 inhibited P. gin-
givalis cell bound proteases, CTT1 inhibited P. micros su-
pernatant proteases and P. intermedia and P. micros cell 
bound proteases. Their gelatinolytic activities were reduced 
when compared with the respective original sample activi-
ties. These differences were statistically significant (P 
 
 
 
 
 
 
 
 
 
Fig. (2). Activation of proMMP-9 by supernatants of the growth media of P. gingivalis (P.g.), P. intermedia (P.i.), P. micros (P.m.), P. ni-
grescens (P.n.), F. nucleatum (F.n.) (Fig. 2) were studied by ECL Western blot. ProMMP-9 was incubated with the supernatants at 37
◦۠ C for 
6 h. All the strains were able to convert the 92 kDa proMMP-9 to the 60 and 77-82 kDa lower molecular size forms of MMP-9. 
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Fig. (3). The ability of proteinase inhibitors to inhibit the bacteria-based gelatinolytic activity was studied by zymography. The test was re-
peated 3 times and the inhibition results were compared to the control data using Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001. 
<0.05). Moreover, ILM affected P. nigrescens supernatant 
proteases, EDTA affected P. nigrescens cell bound prote-
ases, CMT308 P. intermedia cell bound proteases and P. 
nigrescens supernatant proteases, CTT1 affected P. nigres-
cens supernatant proteases, and PFB affected P. intermedia 
cell bound proteases even more significantly by reducing the 
enzyme activities (P <0.01). In general, it seemed that all 
these tested synthetic inhibitors affected more effectively the 
bacterial cell bound proteases than the tested supernatant 
proteasesas shown in Fig. (3A and B).  
 Because  A. actinomycetemcomitans and F. nucleatum 
showed weak gelatinolytic activities in their supernatant 
samples and partly in the A. actinomycetemcomitans cell 
fractions, the effects of synthetic inhibitors were not tested 
for A. actinomycetemcomitans and F. nucleatum. 
DISCUSSION 
  The present results showed a highly complex pattern of 
proteinase activities of the different bacterial strains investi-
virulence. This was particularly clearly seen with P. gin-
givalis which is known to exert also systemic e
gated which may, at least in part, indicate differences in their 
ffects [26]. 
Our data on A. actinomycetemcomitans are totally new but 
t show strong proteolytic activity, however.  
n
-
like proteinases named as ginginpains or gingivains, three 
this strain did no
  Inflammatory and immune reactions against periodontal 
pathogens are thought to trigger periodontal tissue destruc-
tion partly mediated by microbial proteolytic enzymes to-
gether with the host-derived MMPs [2, 20, 21]. The micro-
bial proteinases also provide nutrients to the bacteria, in the 
form of small peptides and amino acids by degrading immu-
noglobulins, clotting factors, proteinase inhibitors and com-
po ents of host connective tissue [21].
 
 We  observed  that  P. gingivalis, P. intermedia, P. micros 
and P. nigrescens not only produced proteolytic enzymes on 
the surface of their membranes, but also release proteinases 
into their surroundings. P. gingivalis yielded multiple mo-
lecular weight bands indicating strong proteolytic capacity in 
accordance with previous studies [21-22]. The major viru-
lence factors of P. gingivalis include two types of trypsin
A. Inhibition of cell fractions
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types of collagenases, serine proteinase dipeptidyl peptidase 
and several kinds of hydrolytic proteinases [23-27]. The re-
ported optimum pH is from 6.0-8.5, with an estimated mo-
lecular weight range from 18-300 kDa [24, 28-29]. At least 
three distinct collagenolytic proteinases are produced by P. 
gingivalis [30-32]. P. gingivalis has also shown serine dipep-
tidyl peptidase activity with pH optimum of 7.5-8.5. Collec-
tively, at the periodontal lesion site, the non-restrained action 
of P. gingivalis proteinases eventually may dysregulate most 
mechanisms controlling inflammatory reaction of the host.  
 F.  nucleatum and the five serotype strains of A. actino-
mycetemcomitans were also found to release proteolytic en-
zymes but with clearly less activity. Except for the sonicated 
cell fraction of A. actinomycetemcomitans, serotypes b, c, 
and e gave the same bands as observed in their supernatant 
samples. Their activities could be significantly inhibited 
when the pH dropped down to 4.5. However, none of the 
other cell preparates of F. nucleatum and A. actinomycetem-
comitans showed any gelatinolytic activity. Our results about 
ne cysteine proteinase 
 
oteinases 
g
 the present investigation.  
an macrophage-like cells to secrete more 
 [46]. However, the present results on 
 and P. intermedia cell bound prote-
A. actinomycetemcomitans partly agree with and further ex-
tend those of Uitto et al. [33] revealing a generally low cell-
associated proteinase activity, and with the results of Wang 
[34] by showing proteolytic activity in the supernatant sam-
ples but in different pH values and molecular weights. Fur-
thermore, this bacterium can degrade native type I collagen 
and synthetic substrate for bacterial collagenases, and the 
activity was found both in the bacterial cellular material and 
in culture medium [35]. A. actinomycetemcomitans has 
shown a novel alanine- and lysine-specific peptidase activity 
[25-26]. It does not produce trypsin-, chymotrypsin-, elas-
tase-, dipeptidylpeptidase- or amimopeptidase-like activities 
[21].  
 Bachrach  et al. [36] reported that F. nucleatum. produced 
a 65 kDa proteinase which could break down extracellular 
matrix proteins, such as fibrinogen and fibronectin as well as 
type I and IV collagens. F. nucleatum and P. micros have 
been shown to lack trypsin-, chymotrypsin-, elastase-, dipep-
tidyl peptidase-, or aminopeptidase-like activity [21].  
 P.  intermedia and P.nigrescens exhibit inhibitor-resistant 
dipeptidyl peptidase activity and argini
activity, which are biochemically very similar to those of P. 
gingivalis but with much weaker activities [21].  
  MMPs produced by inflammatory cells and tissue cells 
play an important role in the degradation and remodeling of 
extracellular matrix. In the pathogenesis of periodontal dis-
ease, tissue destruction caused by MMPs appears to be one
of the pathogenic mechanisms [1-2, 37]. MMPs have been 
found to be processed in periodontitis-affected gingival tis-
sues, oral fluids and even in dental plaque [5-9, 37]. Most 
likely MMP processing and activation in vivo involves co-
operative action of tissue, plasma and microbial pr
to ether with oxidative stress [37-38].
 Okamoto et al. [38] 
investigated
  the modulation potential of various bacterial 
proteinases against
 proMMPs purified from human neutro-
phils (proMMP-8
 and -9) and from human fibrosarcoma cells 
(proMMP-1). Among the six different
 bacterial proteinases, 
thermolysin family enzymes (family M4)
 such as Pseudomo-
nas aeruginosa elastase,  Vibrio cholerae proteinase,
  and 
thermolysin could efficiently activate all three proMMPs. 
The
 results indicate that certain bacterial proteinases can play 
an important
 role in the regulation of the tissue destruction at 
the site of infections [39]. Min et al. [40] described a novel 
biological activity of LPS preparations in promotion of ex-
tracellular matrix proteolysis by the degradation
  of pro-
teinase inhibitor and the conversion of proMMP-9
 by serine 
proteinases trypsin and plasmin.  
 Seguier  et al. [41] suggested that MMP-9 could be a 
marker for the clinical severity of periodontal disease. It has 
been suggested that proteinases expressed by the infecting 
periodontal pathogens might activate latent host proMMPs to 
initiate or accelerate degradation of the collagenous perio-
dontal ligament [42]. Earlier studies on the activation effect 
of some periodontal pathogens to proMMPs mainly focused 
on proMMP-8 and only few investigations studied the con-
version of proMMP-9 as we did in
  Periodontal pathogens such as P. gingivalis, A. actinomy-
cetemcomitans and also Chlamydia pneumoniae in concert 
with inflammatory cytokines have been reported to induce 
processing of the host MMPs and lead to their over-
expression [43]. A proteinase from P. gingivalis was shown 
to modulate MMP-1, MMP-3 and MMP-8 and also induce 
secretion of collagenase from
  gingival fibroblast [44]. A. 
actinomycetemcomitans has only been reported to trigger 
MMP-8 release and processing by human neutrophils [45], 
and stimulate hum
MMPs in vitro [46].  
  In the present study, all the species of P. gingivalis, P. 
intermedia, P. micros, P. nigrescens, F. nucleatum and all 
the five serotypes of A. actinomycetemcomitans could proc-
ess and fragment the 92 kDa recombinant proMMP-9 to its 
lower molecular size species, some of which corresponded to 
the active forms with molecular weights around 60-82 kDa 
[18,40]. The results on P. gingivalis activation of proMMP-9 
are also in accordance with results of previous studies and F. 
nucleatum showed results similar to what Grenier and 
Grignon have reported
P. intermedia, P. micros, P. nigrescens and A. actinomy-
cetemcomitans strains are new and have not been reported 
earlier.  
  The possibility of synthetic proteinase inhibitors to limit 
or retard the bacteria-induced tissue destruction was also 
addressed in the present investigation. We studied the vari-
ous synthetic MMPIs (ILM, EDTA, CMT3, CMT308, 
CTT1) and a serine proteinase inhibitor Pefabloc for their 
possible inhibition of proteolytic activity of the periodontal 
bacteria P. gingivalis, P. intermedia, P. micros, P. nigres-
cens. The results showed slight but, however, significant 
inhibitory effect of ILM on P. micros cell bound proteases, 
EDTA on P. gingivalis
ases and on P. nigrescens supernatant proteases, CMT3 on 
P. intermedia cell bound proteases, CMT308 on P. gin-
givalis cell bound proteases, CTT1 on P. micros supernatant 
proteases and on P. intermedia and  P. micros cell bound 
proteases. Furthermore, a suppressive function of their ge-
latinolytic activity was observed with ILM on P. nigrescens 
supernatant proteases, EDTA on P. nigrescens cell bound 
proteases, CMT308 on P. intermedia cell bound proteases 
and on P. nigrescens supernatant proteases, and CTT1 on P. 
nigrescens supernatant proteases. Synthetic MMP-inhibitors, 
either selective (CTT-1) or non-selective (ILO, EDTA, 
CMTs), reduce the bacterial proteinase activities in a non-
specific manner and with the same efficiency [1, 19, 37]. Proteolytic Activity of Oral Bacteria  The Open Dentistry Journal, 2008, Volume 2    101 
Pefabloc showed a more pronounced effect on P. intermedia 
cell bound proteases. In general, it seemed that all these syn-
thetic proteinase inhibitors demonstrated more efficient inhi-
bition of cell fraction bound microbial proteinases than on 
proteinases released into the culture medium. Overall, our 
findings together with Grenier et al. [47] suggest that certain 
synthetic anti-proteolytics eventually together with some 
anti-microbial agents can affect the survival and proteolytic 
agents of periodontopathogenic bacteria.  
  In conclusion, the present results showed that the several 
periodontal bacteria investigated, i.e., P. gingivalis, P. inter-
media, P. micros, P. nigrescens, F. nucleatum and A. actin-
omycetemcomitans, can produce cell bound and extracellular 
gelatinolytic proteinases which, in turn, may activate latent 
proMMP-9. This may suggests a co-operative cascade in the 
pathogenesis of oral tissue destruction. Synthetic proteinase 
inhibitors such as MMPIs and Pefabloc exhibit slight inhibi-
tory effects on the proteolytic activities of these bacteria 
without inhibiting them completely, however. In future such 
n
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